Dr. Reddy's launches generic cancer injection

G Naga Sridhar Hyderabad | Updated on January 09, 2018

Dr. Reddy’s Laboratories Ltd has launched Melphalan Hydrochloride for Injection, a therapeutic equivalent generic version of Alkeran (melphalan hydrochloride) for Injection used in the treatment of certain types of cancer and approved in the US market by the US Food and Drug Administration (USFDA).

The Alkeran brand and generic drug had US sales of approximately $107 million for the most recent twelve months ending in October 2017 according to IMS Health, according to a release.

Dr. Reddy’s Melphalan Hydrochloride for Injection is available in a carton containing one single-dose clear glass vial of freeze-dried melphalan hydrochloride equivalent to 50 mg melphalan and one 10 mL clear glass vial of sterile diluent.

Published on December 26, 2017

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like